ER regulates an evolutionarily conserved apoptosis pathway

Biochemical and Biophysical Research Communications

Volumn 400, Issue 1, 2010, Pages 34-38

  Liu, Zhihua ^a   Chen, Shilin ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

Apoptosis; ChIP chip; Cis Regulatory element; Estrogen receptor; Lineage specific selection

Indexed keywords

ESTROGEN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; FOXA1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; BREAST TUMOR; FEMALE; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETICS; METABOLISM; MOLECULAR EVOLUTION; PATHOLOGY; REGULATORY SEQUENCE; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; FEMALE; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; RECEPTORS, ESTROGEN; REGULATORY ELEMENTS, TRANSCRIPTIONAL;

EID: 84755160709     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.132     Document Type: Article

References (38)

1. Jordan V.C., Brodie A.M. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids 2007, 72:7-25.
2. Treeck O., Juhasz-Boess I., Lattrich C., Horn F., Goerse R., Ortmann O. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines. Breast Cancer Res. Treat. 2008, 110:507-520.
3. Hodges-Gallagher L., Valentine C.D., El Bader S., Kushner P.J. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Res. Treat. 2008, 109:241-250.
4. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., Wang Q., Bekiranov S., Sementchenko V., Fox E.A., Silver P.A., Gingeras T.R., Liu X.S., Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38:1289-1297.
5. Hostanska K., Nisslein T., Freudenstein J., Reichling J., Saller R. Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res. Treat. 2004, 84:151-160.
6. Deyrup A.T., Tretiakova M., Montag A.G. Estrogen receptor-beta expression in extraabdominal fibromatoses: an analysis of 40 cases. Cancer 2006, 106:208-213.
7. Badve S., Turbin D., Thorat M.A., Morimiya A., Nielsen T.O., Perou C.M., Dunn S., Huntsman D.G., Nakshatri H. FOXA1 expression in breast cancer - correlation with luminal subtype A and survival. Clin. Cancer Res. 2007, 13:4415-4421.
8. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., Fox E.A., Silver P.A., Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
9. Liu Y., Liu X.S., Wei L., Altman R.B., Batzoglou S. Eukaryotic regulatory element conservation analysis and identification using comparative genomics. Genome Res. 2004, 14:451-458.
10. A. Siepel, K.S. Pollard, D. Haussler, New methods for detecting lineage-specific selection, in: Proceedings of the 10th International Conference on Research in Computational Molecular Biology (RECOMB), vol. 3909, 2006, pp. 190-205.
11. Lupien M., Eeckhoute J., Meyer C.A., Wang Q., Zhang Y., Li W., Carroll J.S., Liu X.S., Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132:958-970.
12. Johnson W.E., Li W., Meyer C.A., Gottardo R., Carroll J.S., Brown M., Liu X.S. Model-based analysis of tiling-arrays for ChIP-chip. Proc. Natl. Acad. Sci. USA 2006, 103:12457-12462.
13. Sandelin A., Wasserman W.W., Lenhard B. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 2004, 32:W249-W252.
14. Hur J., Chesnes J., Coser K.R., Lee R.S., Geck P., Isselbacher K.J., Shioda T. The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. Proc. Natl. Acad. Sci. USA 2004, 101:2351-2356.
15. Kurtev V., Margueron R., Kroboth K., Ogris E., Cavailles V., Seiser C. Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. J. Biol. Chem. 2004, 279:24834-24843.
16. Giacinti L., Claudio P.P., Lopez M., Giordano A. Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 2006, 11:1-8.
17. Yang X., Ferguson A.T., Nass S.J., Phillips D.L., Butash K.A., Wang S.M., Herman J.G., Davidson N.E. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. Cancer Res. 2000, 60:6890-6894.
18. Itoh T., Karlsberg K., Kijima I., Yuan Y.C., Smith D., Ye J., Chen S. Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach. Mol. Cancer Res. 2005, 3:203-218.
19. Cestac P., Sarrabayrouse G., Medale-Giamarchi C., Rochaix P., Balaguer P., Favre G., Faye J.C., Doisneau-Sixou S. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity. Breast Cancer Res. 2005, 7:R60-R70.
20. Adam L., Vadlamudi R., Kondapaka S.B., Chernoff J., Mendelsohn J., Kumar R. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J. Biol. Chem. 1998, 273:28238-28246.
21. Adam L., Vadlamudi R., Mandal M., Chernoff J., Kumar R. Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1. J. Biol. Chem. 2000, 275:12041-12050.
22. Vadlamudi R.K., Adam L., Wang R.A., Mandal M., Nguyen D., Sahin A., Chernoff J., Hung M.C., Kumar R. Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J. Biol. Chem. 2000, 275:36238-36244.
23. Balasenthil S., Sahin A.A., Barnes C.J., Wang R.A., Pestell R.G., Vadlamudi R.K., Kumar R. P21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells. J. Biol. Chem. 2004, 279:1422-1428.
24. Wang R.A., Mazumdar A., Vadlamudi R.K., Kumar R. P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium. EMBO J. 2002, 21:5437-5447.
25. Balasenthil S., Barnes C.J., Rayala S.K., Kumar R. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells. FEBS Lett. 2004, 567:243-247.
26. Rayala S.K., Talukder A.H., Balasenthil S., Tharakan R., Barnes C.J., Wang R.A., Aldaz C.M., Khan S., Kumar R. P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation. Cancer Res. 2006, 66:1694-1701.
27. Holm C., Rayala S., Jirstrom K., Stal O., Kumar R., Landberg G. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J. Natl. Cancer Inst. 2006, 98:671-680.
28. Veyrieras J.B., Kudaravalli S., Kim S.Y., Dermitzakis E.T., Gilad Y., Stephens M., Pritchard J.K. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 2008, 4:e1000214.
29. Baldwin A.S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 2001, 107:241-246.
30. Lin Q., Lai R., Chirieac L.R., Li C., Thomazy V.A., Grammatikakis I., Rassidakis G.Z., Zhang W., Fujio Y., Kunisada K., Hamilton S.R., Amin H.M. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am. J. Pathol. 2005, 167:969-980.
31. Khera S., Chang N.S. TIAF1 participates in the transforming growth factor beta1-mediated growth regulation. Ann. N.Y. Acad. Sci. 2003, 995:11-21.
32. Miller L.D., Smeds J., George J., Vega V.B., Vergara L., Ploner A., Pawitan Y., Hall P., Klaar S., Liu E.T., Bergh J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl. Acad. Sci. USA 2005, 102:13550-13555.
33. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., Borresen-Dale A.L., Brown P.O., Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
34. Kumar R., Mandal M., Lipton A., Harvey H., Thompson C.B. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells. Clin. Cancer Res. 1996, 2:1215-1219.
35. Hernandez-Vargas H., Rodriguez-Pinilla S.M., Julian-Tendero M., Sanchez-Rovira P., Cuevas C., Anton A., Rios M.J., Palacios J., Moreno-Bueno G. Gene expression profiling of breast cancer cells in response to gemcitabine: NF-kappaB pathway activation as a potential mechanism of resistance. Breast Cancer Res. Treat. 2007, 102:157-172.
36. McGrogan B.T., Gilmartin B., Carney D.N., McCann A. Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta 2008, 1785:96-132.
37. Ciucci A., Gianferretti P., Piva R., Guyot T., Snape T.J., Roberts S.M., Santoro M.G. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway. Mol. Pharmacol. 2006, 70:1812-1821.
38. Nucera C., Eeckhoute J., Finn S., Carroll J.S., Ligon A.H., Priolo C., Fadda G., Toner M., Sheils O., Attard M., Pontecorvi A., Nose V., Loda M., Brown M. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin. Cancer Res. 2009, 15:3680-3689.